𝔖 Bobbio Scriptorium

✦ LIBER ✦

Which bisphosphonates do oncologists prescribe for women with metastatic breast cancer and why? Results of a UK survey

✍ Scribed by Lesley Fallowfield; Valerie Jenkins; Robert Coleman

Book ID: 113507027
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 232 KB
Volume: 17
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2008.02.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of the combination o

Safety and efficacy of the combination of trastuzumab with docetaxel for HER2-positive women with advanced breast cancer. A review of the existing clinical trials and results of the expanded access programme in the UK

✍ K.T. Papazisis; T. Habeshaw; D.W. Miles 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

First results of a randomized phase III

First results of a randomized phase III trial comparing exemestane versus tamoxifen as first-line hormone therapy (HT) for postmenopausal women with metastatic breast cancer (MBC) — EORTC 10951 in collaboration with the exemestane working group and NCIC Clinical Trials Group

✍ R Paridaens; P Therasse; L Dirix; L Beex; M.J Piccart; D Cameron; T Cufer; K Roo 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 172 KB